Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers Health (NYSE:HIMS) Hits New 1-Year High on Analyst Upgrade

Hims & Hers Health (NYSE:HIMS) Hits New 52-Week High on Analyst Upgrade…

Why Hims & Hers Health (HIMS) Is Rallying Today

By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able "to support at-home blood draws…

Hims & Hers Buys At-Home Lab Testing Facility

Hims & Hers Health Inc: * HIMS…

Hims & Hers Soars 18% on At-Home Testing Expansion

Hims & Hers Health Inc. (HIMS) shares surged over 18% to $69.20, hitting new all-time highs after announcing the expansion…

Hims & Hers Acquires Kearny Lab To Launch At-Home Blood Testing

Hims & Hers is introducing at-home laboratory testing, expanding its platform to offer deeper health insights and more precise clinical…

Hims & Hers is getting into the at-home blood testing business

Hims & Hers announced today that it has acquired Sigmund NJ, bringing at-home blood tests to its platform…

Hims & Hers is getting into the at-home blood testing business

After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) is now expanding its…

Hims & Hers Buys Lab to Expand Into At-Home Blood Testing

(Bloomberg) -- Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the…

Hims & Hers Health stock soars on Trybe Labs acquisition By Investing.com

Hims & Hers Health stock soars on Trybe Labs acquisition…

Why Hims & Hers Health Shares Are Surging

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers buys lab to expand into at-home blood testing

Many Americans have turned to Hims & Hers and other telehealth companies for copies of weight-loss drugs after struggling to…

Hims & Hers to offer at-home blood draws and lab testing with new acquisition

Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.…

Hims & Hers stock in focus on Trybe Labs buyout (HIMS:NYSE)

Hims & Hers (NYSE:HIMS) stock in focus as the company expands telehealth services with the acquisition of at-home lab testing…

Hims & Hers acquires at-home lab testing facility, terms undisclosed

Hims Hers announced its plans to introduce at-home lab testing through its platform. The company has acquired an at-home…

Hims & Hers Buys Lab to Expand Into At-Home Blood Testing

Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the acquisition of…

Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition

Hims & Hers Health shares jumped some 20% to a record high on Wednesday following the announcement that it acquired…

Hims & Hers price target raised to $68 from $38 at Canaccord

Canaccord raised the firm’s price target on Hims Hers to $68 from $38 and keeps a Buy rating on…

Hims & Hers Q4 Preview: Is The Super Bowl Ad Worth $5B In Market Cap? (Rating Downgrade)

…

Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers

Hims & Hers Health, Inc., the leading health and wellness platform, today announced its plans to introduce at-home lab testing…

Hims & Hers Health Shares Fall After Morgan Stanley Downgrade

Hims & Hers Health shares were down more than 2% in recent Tuesday trading after Morgan Stanley downgraded the…

Hims & Hers Earnings Could Be a Game Changer—What to Do Now

After a massive 500% run over the past 12 months, shares of Hims & Hers stock might have another trick…

Hims & Hers Earnings Could Be a Game Changer—What to Do Now

After a massive 500% run over the past 12 months, shares of Hims & Hers stock might have another trick…

Hims & Hers stock downgraded at Morgan Stanley (HIMS:NYSE)

Hims & Hers (HIMS) stock dips as Morgan Stanley downgrades the telehealth firm citing its recent rally in share price.…

Morgan Stanley Downgrades Hims & Hers Health to Equalweight From Overweight, Adjusts Price Target to $60 From $42

Hims & Hers Health has an average rating of overweight and mean price target of $33.33, according to analysts…

Hims & Hers: From Viral Ad to Volatile Stock

Hims & Hers leverages its viral Super Bowl advertisement and strategic weight loss market entry to achieve stock gains and…

Hims & Hers: From Viral Ad to Volatile Stock - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Healths (NYSE:HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time record…

Hims & Hers: From Viral Ad to Volatile Stock

Hims & Hers Healths (NYSE: HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time…

HIMS Stock: What Comes After the Nine-Fold Jump?

The stock price of Hims & Hers Health (NYSE: HIMS), a telehealth platform, has risen a stellar 43% in a…

Hims & Hers price target raised to $85 from $35 at BTIG

BTIG analyst David Larsen raised the firm’s price target on Hims Hers (HIMS) to $85 from $35 and keeps…

BTIG raises Hims & Hers stock price target to $85, maintains buy rating By Investing.com

BTIG raises Hims & Hers stock price target to $85, maintains buy rating…

Hims & Hers Health: Navigating Growth Potential Amidst Elevated Stock Expectations and GLP-1 Volatility

Hims & Hers Health (HIMS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today.…

Hims & Hers Health Stock: A Millionaire-Maker in the Making?

The stock has sprinted past $50 per share, after trading at $3 less than two years ago.…

Hims & Hers Health Stock: A Millionaire-Maker in the Making? @themotleyfool #stocks $HIMS

The stock has sprinted past $50 per share, after trading at $3 less than two years ago.…

Why Hims & Hers Health, Inc. (HIMS) Soared Last Week

We recently compiled a list of the Last Weeks Top 10 Stocks Post Double-Digit Gains. In this article, we are going…

Hims & Hers Health (HIMS) to Release Earnings on Monday

Hims & Hers Health (NYSE:HIMS) will be releasing earnings after the market closes on Monday, February 24, Financial Modeling…

Hims & Hers Health (NYSE:HIMS) Reaches New 12-Month High

Hims & Hers Health (NYSE:HIMS) Hits New 12-Month High - Heres Why…

Hims & Hers Health (NYSE:HIMS) Sees Large Volume Increase

Hims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading Volume - Whats Next?…

Louisiana State Employees Retirement System Acquires Shares of 92,400 Hims & Hers Health, Inc. (NYSE:HIMS)

Louisiana State Employees Retirement System acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS -…

Hims & Hers health COO Melissa Baird sells $3 million in stock

Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc. (NYSE:HIMS), has recently sold a significant portion of…